US-based Wayfinder Biosciences has entered into a collaboration with Japanese pharma firm Daiichi Sankyo to develop RNA-...
Hapatune LLC, a leading global marketing boutique for bioprocess and life science tools and service providers, has annou...
Nikon CeLL innovation (NCLi), a subsidiary of Japan-based Nikon Corporation has entered into a strategic licensing agree...
Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovatio...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
To meet growing demand from the pharmaceutical industry, Japan-based Asahi Kasei has established Asahi Kasei Life Scienc...
AGC Biologics has announced a strategic decision about the large-scale single-use technology it will use at it...
Japan-based Marubeni Corporation has concluded a Share Purchase Agreement with Sumitomo Pharma Co. to acquire shares in ...
Astellas Pharma Inc. and Japanese Foundation for Cancer Research have entered into a strategic collaboration to accelera...
Mitsubishi Corporation (MC), Mitsubishi Corporation Urban Development (MCUD), and iPark Institute Co. (iPi) have announc...
Shin-Etsu Chemical will make investments at two of its bases, the subsidiary SE Tylose GmbH & Co. KG (Wiesbaden...
Japanese pharmaceutical company Shionogi & Co. has entered into an exclusive licensing agreement with Link Medical P...
NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), is expanding its presence in Japa...
Japan's Shin Nippon Biomedical Laboratories (SNBL) and Tasso, Inc., the Seattle-based leading provider of patient-centri...
Alumis Inc., a US-based clinical-stage biopharmaceutical company and Japan's Kaken Pharmaceutical Co. have entered into ...
Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has an...
Japan-based Taiho Pharmaceutical and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibod...
Japan's Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.7 b...
